About
Anagin develops novel targeted therapies to address disrupted synaptic plasticity in the central nervous system for the treatment of neuropsychiatric disorders including PTSD, depression, neuropathic pain, Alzheimer's disease, and Parkinson's disease.
Explore Anagin's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.